Please note that the number of employees in paragraph 5 refers to Novartis, not Sandoz as wrongly stated in the original copy.

Basel, 2 February - Sandoz, the generics arm of Swiss drug maker Novartis, is set to reassess its operations across the globe. However, its Slovenian subsidiary, Lek Sandoz, does not have to fear for the future, having been described as "one of our jewels" by Sandoz CEO Richard Francis.